EAM
REGN icon

Erste Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$27.9M Buy
53,397
+16,364
+44% +$8.54M 0.23% 97
2025
Q1
$23.6M Sell
37,033
-3,349
-8% -$2.13M 0.3% 83
2024
Q4
$28.6M Sell
40,382
-257
-0.6% -$182K 0.35% 70
2024
Q3
$42.5M Buy
40,639
+1,806
+5% +$1.89M 0.51% 52
2024
Q2
$40.8M Sell
38,833
-3,115
-7% -$3.27M 0.54% 52
2024
Q1
$40.5M Buy
41,948
+1,068
+3% +$1.03M 0.55% 54
2023
Q4
$36M Buy
40,880
+2,410
+6% +$2.12M 0.53% 56
2023
Q3
$32.1M Sell
38,470
-1,383
-3% -$1.15M 0.55% 60
2023
Q2
$28.2M Buy
39,853
+413
+1% +$293K 0.5% 62
2023
Q1
$32M Buy
39,440
+7,292
+23% +$5.92M 0.61% 51
2022
Q4
$23.2M Sell
32,148
-1,987
-6% -$1.43M 0.49% 62
2022
Q3
$23.6M Buy
34,135
+857
+3% +$593K 0.53% 57
2022
Q2
$19.9M Buy
33,278
+1,077
+3% +$644K 0.44% 65
2022
Q1
$22.3M Sell
32,201
-1,055
-3% -$730K 0.43% 65
2021
Q4
$21.5M Sell
33,256
-1,714
-5% -$1.11M 0.39% 76
2021
Q3
$21.2M Buy
34,970
+3,500
+11% +$2.12M 0.42% 76
2021
Q2
$17.2M Sell
31,470
-1,650
-5% -$901K 0.34% 82
2021
Q1
$15.6M Buy
33,120
+250
+0.8% +$118K 0.38% 76
2020
Q4
$15.9M Sell
32,870
-2,800
-8% -$1.36M 0.44% 71
2020
Q3
$20.5M Sell
35,670
-330
-0.9% -$189K 0.7% 41
2020
Q2
$22M Buy
36,000
+26,500
+279% +$16.2M 0.88% 27
2020
Q1
$4.49M Hold
9,500
0.26% 111
2019
Q4
$3.55M Hold
9,500
0.16% 142
2019
Q3
$2.6M Hold
9,500
0.14% 156
2019
Q2
$2.95M Sell
9,500
-7,850
-45% -$2.44M 0.16% 138
2019
Q1
$7.02M Sell
17,350
-8,550
-33% -$3.46M 0.39% 59
2018
Q4
$9.45M Buy
+25,900
New +$9.45M 0.63% 36